My watch list  

Umbilical Cord Blood

News Umbilical Cord Blood

  • Amylon Therapeutics wins Startup Slam Competition at BIO-Europe® Berlin

    Amylon Therapeutics was today announced as the winner of the Startup Slam competition at this year’s BIO-Europe® 2017 annual conference in Berlin. Thomas de Vlaam, CEO and founder of Amylon Therapeutics, will receive a complimentary registration to BIO-Europe® Spring 2018 from EBD Group and the oppo more

  • Attacking tumors from the inside

    The targeted delivery of drugs directly into cancer cells is becoming an increasingly common method of ensuring more accurate, safer cancer treatments. Scientists are now exploring the concept of using specially-created groups of immune cells to carry biologics – drugs derived from natural sources s more

  • Stowers scientists successfully expand bone marrow-derived stem cells in culture

    All stem cells — regardless of their source — share the remarkable capability to replenish themselves by undergoing self-renewal. Yet, so far, efforts to grow and expand scarce hematopoietic (or blood-forming) stem cells in culture for therapeutic applications have been met with limited success.Now, more

All news on umbilical cord blood

Publications Umbilical Cord Blood

All publications on umbilical cord blood

Market studies Umbilical Cord Blood

  • Global Cord Blood Banking Market: Focus on China

    Umbilical cord carries rich nutrient blood and gases to the fetus through arteries and veins it encloses. Blood contained in the umbilical cord is rich in stem cells. In the adult body, there are few active sites of blood cell production. Throughout an individual’s life, they are responsible for pro more

  • BIONET Corp. (1784) - Financial and Strategic SWOT Analysis Review

    BIONET Corp. (BIONET) is a publicly held stem cell bank engaged in the collection, processing, storage and commercialization of newborn stem cells from umbilical cord blood. The company conducts regenerative research using stem cells to cure various blood diseases such as thalassemia, leukemia, inhe more

  • VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

    Vita 34 International AG (Vita 34) is a publicly held biotechnology company. It operates as a umbilical cord blood bank. The company is principally engaged in the processing, testing and long-term storage and also sale of samples of stem cells from human umbilical cord blood for the treatment of var more


Percutaneous umbilical cord blood sampling

Percutaneous umbilical cord blood sampling Percutaneous umbilical cord blood sampling (PUBS), also called cordocentesis, is a diagnostic genetic test that examines blood from the fetal umbilical cord to detect fetal abnormalities. PUBS provi ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE